BioAtla BCAB
NASDAQ BCAB
$3.18 -0.05 (-1.55%)
At close: Aug 20, 2026 · 4:00 PM EDT

BioAtla (BCAB) EPS (Basic) (2020 - 2026)

BioAtla (BCAB) posted quarterly EPS (Basic) of -$6.19 for Q1 2026, up 58.82% year-over-year from -$3.9 in Q1 2025, and up 20.72% quarter-over-quarter from -$7.8 in Q4 2025.

BioAtla (BCAB) EPS (Basic) (2020 - 2026) Analysis & Trends

BioAtla's EPS (Basic) history runs 7 years deep, the most recent figure standing at -$6.19 for Q1 2026.

  • In Q1 2026, EPS (Basic) rose 58.82% year-over-year to -$6.19; the TTM figure through Mar 2026 stood at -$39.97 (up 31.33% YoY), while the FY2025 annual figure was -$148.22, up 16.88% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$6.19, up from -$7.8 in the prior quarter.
  • The five-year high for EPS (Basic) was -$6.19 in Q1 2026, with the low at -$3677.7 in Q3 2022.
  • The 5-year median for EPS (Basic) is -$28.44 (2023), against an average of -$277.07.
  • The sharpest annual moves came in 2022 and 2023: EPS (Basic) tumbled 10777.33% in 2022, then soared 99.03% in 2023.
  • BioAtla's EPS (Basic) stood at -$35.85 in 2022, then grew by 20.69% to -$28.44 in 2023, then surged by 43.18% to -$16.16 in 2024, then surged by 51.7% to -$7.8 in 2025, then climbed by 20.72% to -$6.19 in 2026.
  • Business Quant data shows BCAB's EPS (Basic) at -$6.19 in Q1 2026, -$7.8 in Q4 2025, and -$13.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 12.62
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 7.59
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.23
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -0.06
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.18
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -0.72
10 BioAtla 5.28 Mn 5.28 Mn - 0.14

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.15
Mar 31, 2026 -6.19
Dec 31, 2025 -7.80
Sep 30, 2025 -13.00
Jun 30, 2025 -22.45
Mar 31, 2025 -15.02
Dec 31, 2024 -16.16
Sep 30, 2024 -12.26
Jun 30, 2024 -23.61
Mar 31, 2024 -491.68
Dec 31, 2023 -28.44
Sep 30, 2023 -35.68
Jun 30, 2023 -140.43
Mar 31, 2023 -29.27
Dec 31, 2022 -35.85
Sep 30, 2022 -3,677.69
Jun 30, 2022 -121.69
Mar 31, 2022 -33.01
Dec 31, 2021 -35.82
Sep 30, 2021 -33.81